In the clinical setting, higher fetuin-A levels were strongly associated with insulin resistance, abdominal obesity, T2DM, extravascular calcification, asymptomatic atherosclerosis, cardiovascular disease, chronic kidney disease, nonalcoholic fatty liver disease and cognitive dysfunction [150,151,152,153,154,155]. This evidence concerns the gene AHSG and metabolic dysfunction-associated steatotic liver disease.